Compare Cytokinetics Inc (CYTK) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Eli Lilly And Co — how do they compare? Cytokinetics Inc trades at $76.66 (market cap $10.78B), while Eli Lilly And Co trades at $1,215.3 (market cap $1.10T). The key difference: Eli Lilly And Co is far larger — about 102× Cytokinetics Inc's market cap, and Eli Lilly And Co pays a 0.56% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | LLY | |
|---|---|---|
Market Cap | $10.78B | $1.10T |
Sector | Technology | Health |
52-Week High | $87.26 | $1.24K |
52-Week Low | $34.31 | $639.43 |
Enterprise Value | $10.88B | $1.14T |
Dividend Yield | — | 0.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cytokinetics (CYTK) trades at $76.76, down 5.67% today, with a bearish technical signal and negative profitability metrics. Recent Q2 2026 earnings beat EPS estimates but missed on revenue, while the company's drug Myqorzo shows strong commercial uptake and regulatory approvals in the UK. Cash flow remains negative from operations, offset by financing activities.
The outlook is mixed: strong analyst buy ratings (97%) and a $111.14 price target suggest upside, but high cash burn, competitive pressures, and lack of profitability pose significant risks. Investment appeal hinges on successful drug commercialization and path to profitability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
